Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men. - Wikidata - awgldk - TriplyDB

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

http://www.wikidata.org/entity/Q35036628

about

Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC.In serum, higher parathyroid hormone but not lower vitamin D is associated with oral squamous cell carcinoma.Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort.Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment.Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients.Cachexia at diagnosis is associated with poor survival in head and neck cancer patients.Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization.

P2860

Q35374106-24B9900F-F9BB-452F-B9D3-53FE07AA1761 Q35934303-78DD7CB2-D107-444E-B4F6-D1245B30AC85 Q37394011-BB151A51-C0C7-4A4E-83F0-BFE130755D28 Q41691671-E4DF6551-98A7-4199-9BB8-2F21CB99E475 Q45770843-0D12F43A-8AD3-483B-9922-DB65C7B350EE Q48308277-DC7BEB04-7F2D-4843-B265-12C9AD70B615 Q54488941-F495C3D5-5C67-47B0-8B52-E20D5B70530D

P2860

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

http://www.wikidata.org/entity/Q35036628

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

@ast

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

@en

type

label

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

@ast

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

@en

prefLabel

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

@ast

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

@en

P1433

Q35036628-E49788D2-ABBB-472A-9131-47BA4E1B57C5

P1476

Q35036628-3AF602E2-40F1-43FC-8665-A2E617FD18A2

P2093

Q35036628-312EC90F-7CFA-4C01-B3BC-6C17B3D9375E

Q35036628-94D77B5D-7982-4908-ACCD-B5638E9E76A7

Q35036628-C2EAA548-1882-45A6-8CCA-4E303D2964C3

Q35036628-CBFDADCF-7FA5-47D1-A1AC-7ACF388E6E53

P2860

Q35036628-015A2E10-0C60-43E1-9675-B8C21CC142E8

Q35036628-016EB696-0069-476D-A22C-FA9A54B15950

Q35036628-0A86AC4A-16BE-4C50-B778-20180F436D4A

Q35036628-123F3614-4B92-40D2-A68D-60FB21AED266

Q35036628-1F620590-6F59-4BE6-80B5-D26C590A644F

Q35036628-209E964C-CFDC-4BD9-8D85-0A3138DEE954

Q35036628-2405542D-F06B-4461-AA18-3BAE3ED28460

Q35036628-27946C4E-95B4-4D94-B2BB-2AF9704E9F7A

Q35036628-3B6BD877-B314-4463-8A6B-53E3FCC9C1C4

Q35036628-4E2282AB-6369-4242-A90F-E7E5B8D7E7F2

P304

Q35036628-EC2269FB-8C72-4C17-AB13-392F7443ED29

P31

Q35036628-22492797-B30E-407F-9982-BDCCAD8F9B4E

P356

Q35036628-8FAB33FA-5BAB-4105-A33B-29A2E630EE81

P433

Q35036628-BE3DCAF0-402E-4E77-A1B6-442E5466CD45

P478

Q35036628-65187224-83D3-43A7-A38D-809CC65822BA

P50

Q35036628-20069964-19D9-425B-B2F3-F601AA65405F

Q35036628-DBAFF23A-F88A-4BF6-AA86-7D1C1813939E

Q35036628-DD68C0FA-1A94-44CB-962A-580B8F58F118

P577

Q35036628-E826A5A5-1C7F-43EC-B5C4-686B02A63A28

P698

Q35036628-567024FE-111F-4EEA-B0BF-0D65F89E3F6A

P921

Q35036628-1277B589-E94D-4DAA-92C4-3D140B08D113

Q35036628-88767BC2-0B6C-497E-9A8E-737262C8466F

P932

Q35036628-22555794-A061-4444-85AB-35100F95E486

P356

1055-9965.EPI-11-0153

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

@en

P2093

Hannah Arem

http://www.w3.org/2001/XMLSchema#string

Kai Yu

http://www.w3.org/2001/XMLSchema#string

Ronald L Horst

http://www.w3.org/2001/XMLSchema#string

Stephanie J Weinstein

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

Human papillomavirus and survival of patients with oropharyngeal cancer.

Smoking and drinking in relation to oral and pharyngeal cancer

Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies

Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

P304

1178-1184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-11-0153

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Demetrius Albanes

Christian C. Abnet

P577

2011-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21527582

http://www.w3.org/2001/XMLSchema#string

P921

P932

3111816

http://www.w3.org/2001/XMLSchema#string